David Repáraz

5PUBLICATIONS
29CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 12, 2024
The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response.

Yaiza Senent, Ana Remírez, David Repáraz

|Jun 04, 2024
Strategies for overcoming tumour resistance to immunotherapy: harnessing the power of radiation therapy.

Katiuska Passelli, David Repáraz, Remy Kinj

|May 09, 2022
Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy.

Flor Navarro, Noelia Casares, Celia Martín-Otal

|Feb 26, 2022
Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?

David Repáraz, Belén Aparicio, Diana Llopiz

|Jun 23, 2019
When Cancer Vaccines Go Viral.

David Repáraz, Diana Llopiz, Pablo Sarobe

Pageof 1

Frequent Collaborators

2 joint publications

Pablo Sarobe

1 joint publications

Flor Navarro

1 joint publications

Noelia Casares

1 joint publications

Celia Martín-Otal